Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06178354 · ClinicalTrials.gov registry record · NA
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
A NA study of Stage II Prostate Cancer AJCC v8 and Stage I Prostate Cancer AJCC v8, sponsored by Marc Dall'Era, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06178354: Recruiting NA study of Stage II Prostate Cancer AJCC v8 and Stage I Prostate Cancer AJCC v8, sponsored by Marc Dall'Era, MD.
NCT06178354 is a NA study of Stage II Prostate Cancer AJCC v8 and Stage I Prostate Cancer AJCC v8 that is actively recruiting participants, run by Marc Dall'Era, MD. The registered enrollment target is 100 participants, below the 115-participant average among 21 other Stage II Prostate Cancer AJCC v8 trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06178354, a NA study of Stage II Prostate Cancer AJCC v8 and Stage I Prostate Cancer AJCC v8, is actively recruiting participants, sponsored by Marc Dall'Era, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the effectiveness of focal ablation with either focal cryotherapy or high intensity frequency ultrasound for the treatment of men with localized prostate cancer. Focal cryotherapy kills tumor cells by freezing them. High intensity frequency ultrasound uses highly focused ultrasound waves to produce heat and destroy tumor cells.
Primary Outcome
Confidence intervals for the pathologic response rate will be calculated using the Wilson score method. Pathologic response rate will be analyzed by baseline clinical and molecular characteristics using univariable and multivariable logistic regression.
Conditions Studied
Interventions
- OTHER Survey Administration
- PROCEDURE Cryosurgery
- PROCEDURE High-Intensity Focused Ultrasound Ablation
Study Locations (1)
California
- University of California Davis Comprehensive Cancer Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-09 |
| Est. Completion | 2029-06 |
| Phase | NA |
What NCT06178354 shows while recruiting
NCT06178354 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 115-participant average among 21 other Stage II Prostate Cancer AJCC v8 trials with a reported enrollment target (13% lower).
The record links to 5 conditions, with Stage II Prostate Cancer AJCC v8 appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT06178354 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06178354 about?
NCT06178354 is a clinical study titled "Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer". This clinical trial evaluates the effectiveness of focal ablation with either focal cryotherapy or high intensity frequency ultrasound for the treatment of men with localized prostate cancer. Focal cryotherapy kills tumor cells by freezing them. High intensity frequency ultrasound uses highly focuse...
What is the current status of trial NCT06178354?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-11-09. Estimated completion is 2029-06.
What conditions does trial NCT06178354 study?
This clinical trial studies the following conditions: Stage II Prostate Cancer AJCC v8, Stage I Prostate Cancer AJCC v8, Localized Prostate Carcinoma, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8.
What interventions are being tested in trial NCT06178354?
The interventions under investigation include: Survey Administration (OTHER), Cryosurgery (PROCEDURE), High-Intensity Focused Ultrasound Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT06178354?
This trial is sponsored by Marc Dall'Era, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06178354 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Prostate Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06178354's enrollment target sits among peer trials
100 8th of 21 higher than 13 of 21 other Stage II Prostate Cancer AJCC v8 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage II Prostate Cancer AJCC v8 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
RECRUITING · NA
-
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
RECRUITING · NA
-
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
RECRUITING · NA
-
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
RECRUITING · NA
-
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
RECRUITING · NA
-
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI